Atrial Functional Mitral Regurgitation: JACC Review Topic of the Week.

[1]  S. Yun,et al.  Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation: PRIME Study , 2019, Circulation.

[2]  R. Levine,et al.  Mitral Valve Adaptation to Isolated Annular Dilation: Insights Into the Mechanism of Atrial Functional Mitral Regurgitation. , 2017, JACC. Cardiovascular imaging.

[3]  C. Hengstenberg,et al.  Papillary Muscle Dyssynchrony-Mediated Functional Mitral Regurgitation: Mechanistic Insights and Modulation by Cardiac Resynchronization. , 2019, JACC. Cardiovascular imaging.

[4]  Jeroen J. Bax,et al.  Impact of atrial fibrillation on improvement of functional mitral regurgitation in cardiac resynchronization therapy. , 2018, Heart Rhythm.

[5]  M. Mack,et al.  Transcatheter Mitral‐Valve Repair in Patients with Heart Failure , 2018, The New England journal of medicine.

[6]  D. Mark,et al.  Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design , 2018, American heart journal.

[7]  B. Gersh,et al.  High Prevalence of Occult Heart Failure With Preserved Ejection Fraction Among Patients With Atrial Fibrillation and Dyspnea. , 2018, Circulation.

[8]  Jeroen J. Bax,et al.  2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European heart journal.

[9]  R. Levine,et al.  Effect of Losartan on Mitral Valve Changes After Myocardial Infarction. , 2017, Journal of the American College of Cardiology.

[10]  L. Fleisher,et al.  2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.

[11]  Shannon M. Dunlay,et al.  Epidemiology of heart failure with preserved ejection fraction , 2017, Nature Reviews Cardiology.

[12]  A. Bayés‐Genís,et al.  Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach , 2017, npj Systems Biology and Applications.

[13]  Yuchi Han,et al.  Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[14]  Kiyoshi Yoshida,et al.  Insufficient Leaflet Remodeling in Patients With Atrial Fibrillation: Association With the Severity of Mitral Regurgitation , 2017, Circulation. Cardiovascular imaging.

[15]  I. V. Van Gelder,et al.  Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume. , 2017, JACC. Heart failure.

[16]  P. Vandervoort,et al.  Exercise Dynamics in Secondary Mitral Regurgitation: Pathophysiology and Therapeutic Implications. , 2017, Circulation.

[17]  L. Allen,et al.  Heart Failure Complicated by Atrial Fibrillation: Don't Bury the Beta-Blockers Just Yet. , 2017, JACC. Heart failure.

[18]  Dipak Kotecha,et al.  The Present and FutureReview Topic of the WeekHeart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins , 2016 .

[19]  N. Sato,et al.  Functional mitral regurgitation at discharge and outcomes in patients hospitalized for acute decompensated heart failure with a preserved or reduced ejection fraction , 2016, European journal of heart failure.

[20]  R. Levine,et al.  Myocardial Infarction Alters Adaptation of the Tethered Mitral Valve. , 2016, Journal of the American College of Cardiology.

[21]  Francesca N. Delling,et al.  Mitral valve disease—morphology and mechanisms , 2015, Nature Reviews Cardiology.

[22]  Y. Abe,et al.  Mitral valve repair for atrial functional mitral regurgitation in patients with chronic atrial fibrillation. , 2015, Interactive cardiovascular and thoracic surgery.

[23]  Liang-ping Zhao,et al.  The role of valvular regurgitation in catheter ablation outcomes of patients with long-standing persistent atrial fibrillation. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[24]  G. Nickenig,et al.  Acute Changes of Mitral Valve Geometry During Interventional Edge-to-Edge Repair With the MitraClip System Are Associated With Midterm Outcomes in Patients With Functional Valve Disease: Preliminary Results From a Prospective Single-Center Study , 2014, Circulation. Cardiovascular interventions.

[25]  D. Dutka,et al.  Mechanisms of atrial mitral regurgitation: insights using 3D transoesophageal echo. , 2014, European heart journal cardiovascular Imaging.

[26]  Sanjiv J Shah,et al.  Spironolactone for heart failure with preserved ejection fraction. , 2014, The New England journal of medicine.

[27]  C. Murray,et al.  Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study , 2014, Circulation.

[28]  Timothy J Gardner,et al.  Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. , 2014, The New England journal of medicine.

[29]  K. Aonuma,et al.  Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction. , 2013, Journal of the American College of Cardiology.

[30]  Alanna M. Chamberlain,et al.  Temporal Relationship and Prognostic Significance of Atrial Fibrillation in Heart Failure Patients With Preserved Ejection Fraction A Community-Based Study , 2013 .

[31]  P. Pibarot,et al.  Secondary Mitral Regurgitation in Heart Failure with Reduced or Preserved Left Ventricular Ejection Fraction , 2013, Cardiology.

[32]  M. Doyle,et al.  Mitral regurgitation recovery and atrial reverse remodeling following pulmonary vein isolation procedure in patients with atrial fibrillation: a clinical observation proof-of-concept cardiac MRI study , 2013, Journal of Interventional Cardiac Electrophysiology.

[33]  S. Solomon,et al.  The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial , 2012, The Lancet.

[34]  M. Acker,et al.  Three-Dimensional Echocardiographic Analysis of Mitral Annular Dynamics: Implication for Annuloplasty Selection , 2012, Circulation.

[35]  M. Keane,et al.  Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control. , 2011, Journal of the American College of Cardiology.

[36]  B. Hoit.  Atrial functional mitral regurgitation: the left atrium gets its due respect. , 2011, Journal of the American College of Cardiology.

[37]  M. Keane,et al.  The impact of mitral regurgitation on patients undergoing catheter ablation of atrial fibrillation. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[38]  J. Junttila,et al.  Respective Prevalence of the Different Carpentier Classes of Mitral Regurgitation: A Stepping Stone for Future Therapeutic Research and Development , 2011, Journal of cardiac surgery.

[39]  M. Pfeffer,et al.  Irbesartan in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[40]  P. Marino,et al.  Atrial asynchrony and function before and after electrical cardioversion for persistent atrial fibrillation. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[41]  Otto Kamp,et al.  Lenient versus strict rate control in patients with atrial fibrillation. , 2010, The New England journal of medicine.

[42]  M. Gold,et al.  Cardiac Resynchronization Induces Major Structural and Functional Reverse Remodeling in Patients With New York Heart Association Class I/II Heart Failure , 2009, Circulation.

[43]  A. Gillinov,et al.  Mitral Regurgitation Associated with Mitral Annular Dilation in Patients with Lone Atrial Fibrillation: An Echocardiographic Study , 2009, Echocardiography.

[44]  Suzanne Sullivan,et al.  Active Adaptation of the Tethered Mitral Valve: Insights Into a Compensatory Mechanism for Functional Mitral Regurgitation , 2009, Circulation.

[45]  J. Gardin,et al.  Burden of valvular heart diseases: a population-based study , 2006, The Lancet.

[46]  M. Pfeffer,et al.  Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. , 2006, American heart journal.

[47]  M. Pfeffer,et al.  Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial. , 2006, American heart journal.

[48]  James B Seward,et al.  Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up. , 2006, European heart journal.

[49]  P. McCarthy,et al.  Mitral valve stiffening in end-stage heart failure: evidence of an organic contribution to functional mitral regurgitation. , 2005, The Journal of thoracic and cardiovascular surgery.

[50]  E. Schwammenthal,et al.  Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. , 2005, Circulation.

[51]  Jeroen J. Bax,et al.  Restrictive Annuloplasty and Coronary Revascularization in Ischemic Mitral Regurgitation Results in Reverse Left Ventricular Remodeling , 2004, Circulation.

[52]  R. Levine,et al.  Mechanism of Recurrent Ischemic Mitral Regurgitation After Annuloplasty: Continued LV Remodeling as a Moving Target , 2004, Circulation.

[53]  M. Böhm,et al.  Increased exercise ejection fraction and reversed remodeling after long‐term treatment with metoprolol in congestive heart failure: a randomized, stratified, double‐blind, placebo‐controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy , 2003, European journal of heart failure.

[54]  Andreas Franke,et al.  Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. , 2003, Journal of the American College of Cardiology.

[55]  A L Waldo,et al.  A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.

[56]  S. Yoshifuku,et al.  Impact of atrial fibrillation on tricuspid and mitral annular dilatation and valvular regurgitation. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[57]  R. Levine,et al.  Isolated annular dilation does not usually cause important functional mitral regurgitation: comparison between patients with lone atrial fibrillation and those with idiopathic or ischemic cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[58]  笹本 貴広,et al.  108)高度房室ブロックによる意識消失発作で発症した悪性リンパ腫の一例(日本循環器学会 第182回関東甲信越地方会) , 2002 .

[59]  T. Levine,et al.  Effects of high-dose lisinopril-isosorbide dinitrate on severe mitral regurgitation and heart failure remodeling. , 1998, The American journal of cardiology.

[60]  H. Crijns,et al.  Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. , 1996, Archives of internal medicine.

[61]  R. Pai,et al.  Effect of isolated left atrial enlargement on mitral annular size and valve competence. , 1996, The American journal of cardiology.

[62]  A Piwnica,et al.  Reconstructive surgery of mitral valve incompetence: ten-year appraisal. , 1980, The Journal of thoracic and cardiovascular surgery.